Ingen Introduces the Oxyview-Cannula Into the $8 Billion Global Respiratory Market

YUCAIPA, Calif., May 19, 2009 (GLOBE NEWSWIRE) -- Ingen Technologies, Inc. (Pink
Sheets:IGNT) a leading Global Medical Device manufacturer focused in the $4
Billion U.S. and $8 Billion global Respiratory Market for the growing ageing
population and emerging markets for Home (DME), Hospital and Aviation Industries
announced today that they have reached an agreement with Legend Medical Devices,
Inc. to combine the Oxyview and cannula together to increase market share.

Legend Medical Devices is a world leading manufacturer and marketer of
respiratory products for anesthesia, respiratory care and infection control. The
company is a subsidiary of Asia Healthcare Holdings focused on developing the
most cost effective medical products that can help the healthcare professionals
achieve quality airway management. Their main business is to design,
manufacture, import and distribute FDA approved and ISO certified medical
products in the U.S. market through business alliances with their subsidiaries
and partnerships with medical manufacturing companies in Asian countries, such
as China, Korea, and other countries.

Ingen Technologies has agreed to purchase the Legend-MD(tm) cannula manufactured
by Legend Medical Devices, and Legend Medical Devices has agreed to package the
Oxyview with their nasal cannulas. Ingen will start selling the Oxyview-Cannula
in June-2009. The company intends to offer the new disposable Oxyview-Cannula at
the same price as the leading competitor's price. "The new product will offer
the home oxygen patients, worldwide, a much better and improved cannula at the
same price as the competition, however. The competitor cannula does not include
a pneumatic flow-meter. This will be the first cannula of its kind offered with
a pneumatic gravity-independent flow meter already attached," stated Chris
Wirth, Chief Operations Officer for Ingen Technologies.

The Oxyview-Cannula allows the patient to verify that they are receiving the
prescribed dosage of oxygen and that their equipment is functioning properly.
Without the Oxyview-Cannula, there is no means to confirm oxygen flow nearest
the patient or whether or not the equipment is working properly. A cannula is
the oxygen tubing and nasal attachment that connects to the delivery equipment
and extends to the patient's nose. The cannula is a disposable item. With the
Oxyview-Cannula, Patients will improve their home oxygen therapy. The company
will continue to sell the individual reusable Oxyview.

"The Oxyview-Cannula will revolutionize the cannula market. There is an
estimated 23 million home oxygen patients in the U.S. that use several cannulas
each month. With the Oxyview-Cannula competitively priced, the patients will now
have a choice between the old-style cannula and ours. This new product is a
win-win for the patients and our company," stated Scott Sand, Chief Executive
Officer of Ingen Technologies.

About Oxyview:

Oxyview is a proprietary medical device with US issued patents that stands alone
in an increasing patient home oxygen therapy market while there are 23 million
patients diagnosed with chronic obstructive pulmonary disease (COPD) in the
United States, according to the World Health Organization, and another 12
million patients that are undiagnosed in the US. COPD is the fifth leading cause
of death in the US and there are 600 million COPD patients worldwide where in
most cases, COPD is either the first or second leading cause of death in other
countries. The majority of COPD patients require continued home oxygen therapy,
which includes all of the required equipment supplied by the home (DME)
provider. With the new regulations for oxygen reimbursement in the US, the home
(DME) providers need to cut costs to stay in business. Oxyview provides a
substantial savings as a result of decreasing the number of service calls for
the home (DME) provider. Oxyview is a pneumatic metering device that displays
oxygen flow near the patient. The Oxyview flow meter easily and quickly installs
on to the oxygen tubing nearest the patient where oxygen flow matters the most.
Without the Oxyview, patients cannot confirm oxygen flow, and as a result there
is an increase in anxiety and the patient calls the home (DME) provider with
concerns. Oxyview also allows the home (DME) provider to trouble-shoot other
equipment problems over the telephone which eliminates an on-site visit with the
patient. More important, the Oxyview provides the patient with more assurance
that they are receiving adequate and prescribed oxygen flow. The Oxyview costs
less than a single service call.

www.ingen-tech.com

http://www.legendmd.com/partners.php

The Ingen Technologies, Inc. logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=2472

Safe Harbor for Forward-Looking Statements: This news release includes
forward-looking statements. While these statements are made to convey to the
public the company's progress, business opportunities and growth prospects,
readers are cautioned that such forward-looking statements represent
management's opinion. Whereas management believes such representations to be
true and accurate based on information and data available to the company at this
time, actual results may differ materially from those described. The company's
operations and business prospects are always subject to risk and uncertainties.
Important factors that may cause actual results to differ are and will be set
forth in the company's periodic filings with the U.S. Securities and Exchange
Commission.

-0-
CONTACT: Ingen Technologies, Inc.
Chris Wirth
909-790-7180
info@ingen-tech.com
www.ingen-tech.com